Mikaela Noel Aldaco-fowler, MA, LMFTA Psychologist - Family Medicare: Not Enrolled in Medicare Practice Location: 6532 Ne 196th Pl, Kenmore, WA 98028 Phone: 425-866-0548 |
Dr. Wayne E Carr, PH.D. Psychologist - Addiction (Substance Use Disorder) Medicare: Medicare Enrolled Practice Location: 7800 N E Bothell Way, Suite 155 B, Kenmore, WA 98028 Phone: 425-488-5496 Fax: 425-952-9275 |
Dr. Yu Chak Sunny Ho, PH.D. Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 14500 Juanita Dr Ne, Kenmore, WA 98028 Phone: 626-297-0890 |
Dr. M. O'donnell Day, PH.D. Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 14840 74th Pl Ne, Kenmore, WA 98028 Phone: 425-802-3000 |
News Archive
A 40 to 80 day treatment with the antiparasitic medication benznidazole significantly reduced parasite activity in the blood, but not progression, of serious heart problems over a 5-year period among patients with established Chagas disease (CD) cardiomyopathy, results of the BENEFIT trial show.
New findings presented yesterday at a National Autism Association meeting bolster claims that vaccines may play a role in the development of autism spectrum disorders.
Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, announced today that new Phase 2b data related to ABT-450, Enanta's lead HCV protease inhibitor identified in its ongoing collaboration with AbbVie, as well as new preclinical data on Enanta's proprietary cyclophilin inhibitor, EDP-546, will be presented at the International Liver Congress, which is the 48th Annual Meeting of the European Association for the Study of the Liver taking place in Amsterdam April 24-28, 2013.
Researchers at the Rothman Institute at Jefferson examined data on patients being treated for lumbar stenosis and the degenerative spine condition spondylolisthesis and found that patients who received epidural steroid injections (ESI) had a higher rate of crossover to surgery and fared worse in physical health and bodily pain versus those who did not receive ESI, dispelling their pre-study hypothesis.
Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today that its subsidiary Wound Care Innovations, LLC has launched the Cifra(TM) healthcare platform to securely exchange and store information for ongoing evidence based case studies on its patented collagen CellerateRx® products in managing all types of wound care.
› Verified 7 days ago